• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于心力衰竭中细胞内和细胞外心肌疾病特征描述的T1映射

T1 Mapping for Characterization of Intracellular and Extracellular Myocardial Diseases in Heart Failure.

作者信息

Maestrini Viviana, Treibel Thomas A, White Steven K, Fontana Marianna, Moon James C

机构信息

The Heart Hospital Imaging Centre, University College London Hospitals, 16-18 Westmoreland Street, London, W1G 8PH UK ; Department of Cardiovascular, Respiratory, Nephrology, Anesthesiology & Geriatric Sciences, Sapienza University, Rome, Italy.

The Heart Hospital Imaging Centre, University College London Hospitals, 16-18 Westmoreland Street, London, W1G 8PH UK ; Institute of Cardiovascular Science, University College London, London, WC1E 6BT UK.

出版信息

Curr Cardiovasc Imaging Rep. 2014;7(9):9287. doi: 10.1007/s12410-014-9287-8.

DOI:10.1007/s12410-014-9287-8
PMID:25152807
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4133016/
Abstract

Heart failure (HF) is a major and growing cause of morbidity and mortality. Despite initial successes, there have been few recent therapeutic advances. A better understanding of HF pathophysiology is needed with renewed focus on the myocardium itself. A new imaging technique is now available that holds promise. T1 mapping is a cardiovascular magnetic resonance (CMR) technique for non-invasive myocardial tissue characterization. T1 alters with disease. Pre-contrast (native) T1 changes with a number of processes such as fibrosis, edema and infiltrations. If a post contrast scan is also done, the extracellular volume fraction (ECV) can be measured, a direct measure of the interstitium and its reciprocal, the cell volume. This dichotomy is fundamental - and now measurable promising more targeted therapy and new insights into disease biology.

摘要

心力衰竭(HF)是发病率和死亡率的主要且不断上升的原因。尽管初期取得了成功,但近期治疗进展甚少。需要更好地理解HF病理生理学,并重新关注心肌本身。现在有一种新的成像技术有望带来突破。T1映射是一种用于无创心肌组织特征分析的心血管磁共振(CMR)技术。T1会随疾病发生改变。对比剂注射前(天然)T1会随着纤维化、水肿和浸润等多种过程而变化。如果同时进行对比剂注射后的扫描,则可以测量细胞外容积分数(ECV),这是对间质及其对应物细胞容积的直接测量。这种二分法至关重要——现在可以测量,有望实现更有针对性的治疗,并为疾病生物学带来新的见解。

相似文献

1
T1 Mapping for Characterization of Intracellular and Extracellular Myocardial Diseases in Heart Failure.用于心力衰竭中细胞内和细胞外心肌疾病特征描述的T1映射
Curr Cardiovasc Imaging Rep. 2014;7(9):9287. doi: 10.1007/s12410-014-9287-8.
2
Native T1 Mapping and Extracellular Volume Mapping for the Assessment of Diffuse Myocardial Fibrosis in Dilated Cardiomyopathy.用于评估扩张型心肌病弥漫性心肌纤维化的 native T1 mapping 和细胞外容积 mapping。
JACC Cardiovasc Imaging. 2018 Jan;11(1):48-59. doi: 10.1016/j.jcmg.2017.04.006. Epub 2017 Jun 14.
3
Tissue Characterization in Cardiology: Moving Beyond Function.心脏病学中的组织特征分析:超越功能。
Adv Exp Med Biol. 2021;1337:89-97. doi: 10.1007/978-3-030-78771-4_11.
4
Prognostic value of cardiovascular magnetic resonance T1 mapping and extracellular volume fraction in nonischemic dilated cardiomyopathy.非缺血性扩张型心肌病中心血管磁共振 T1 映射和细胞外容积分数的预后价值。
J Cardiovasc Magn Reson. 2023 Feb 6;25(1):7. doi: 10.1186/s12968-023-00919-y.
5
Electrocardiogram-less, free-breathing myocardial extracellular volume fraction mapping in small animals at high heart rates using motion-resolved cardiovascular magnetic reesonance multitasking: a feasibility study in a heart failure with preserved ejection fraction rat model.使用运动分辨心血管磁共振多任务技术在高心率下对小动物进行无心电图、自由呼吸心肌细胞外体积分数成像:射血分数保留心力衰竭大鼠模型中的可行性研究。
J Cardiovasc Magn Reson. 2021 Feb 11;23(1):8. doi: 10.1186/s12968-020-00699-9.
6
Prognostic value of heart failure in hemodialysis-dependent end-stage renal disease patients with myocardial fibrosis quantification by extracellular volume on cardiac magnetic resonance imaging.心脏磁共振成像心肌纤维化外体积定量评估对血液透析依赖的终末期肾病伴心力衰竭患者的预后价值。
BMC Cardiovasc Disord. 2020 Jan 10;20(1):12. doi: 10.1186/s12872-019-01313-2.
7
Myocardial fibrosis by T1 mapping magnetic resonance imaging predicts incident cardiovascular events and all-cause mortality: the Multi-Ethnic Study of Atherosclerosis.T1 映射磁共振成像预测心肌纤维化与心血管事件和全因死亡率的发生:动脉粥样硬化的多民族研究。
Eur Heart J Cardiovasc Imaging. 2022 Sep 10;23(10):1407-1416. doi: 10.1093/ehjci/jeac010.
8
Comprehensive cardiac magnetic resonance T1, T2, and extracellular volume mapping to define Duchenne cardiomyopathy.综合心脏磁共振 T1、T2 和细胞外容积成像用于定义杜氏肌营养不良症的心肌病变。
J Cardiovasc Magn Reson. 2023 Jul 31;25(1):44. doi: 10.1186/s12968-023-00951-y.
9
Histological Validation of measurement of diffuse interstitial myocardial fibrosis by myocardial extravascular volume fraction from Modified Look-Locker imaging (MOLLI) T1 mapping at 3 T.通过3T场强下改良Look-Locker成像(MOLLI)T1映射的心肌血管外容积分数对弥漫性间质心肌纤维化测量的组织学验证
J Cardiovasc Magn Reson. 2015 Jun 11;17(1):48. doi: 10.1186/s12968-015-0150-0.
10
T1 and T2 Mapping in Cardiology: "Mapping the Obscure Object of Desire".心脏病学中的T1和T2映射:“描绘难以捉摸的心仪对象”
Cardiology. 2017;138(4):207-217. doi: 10.1159/000478901. Epub 2017 Aug 17.

引用本文的文献

1
Cardiac magnetic resonance in systemic sclerosis: imaging features and potential prognostic implications. A literature review.系统性硬化症的心脏磁共振成像:影像学特征及潜在预后意义。文献综述。
Front Med (Lausanne). 2025 Aug 15;12:1606593. doi: 10.3389/fmed.2025.1606593. eCollection 2025.
2
Review of Myocardial Ischemia, Scar, and Viability Estimation with Molecular Magnetic Resonance Imaging.分子磁共振成像对心肌缺血、瘢痕和存活心肌评估的综述
Biomedicines. 2024 Jul 27;12(8):1681. doi: 10.3390/biomedicines12081681.
3
T1 mapping: a non-invasive tool to assess the systemic right ventricle.

本文引用的文献

1
Native T1 mapping in transthyretin amyloidosis.转甲状腺素蛋白淀粉样变性的 native T1 mapping。
JACC Cardiovasc Imaging. 2014 Feb;7(2):157-65. doi: 10.1016/j.jcmg.2013.10.008. Epub 2014 Jan 8.
2
Myocardial damage detected by late gadolinium enhancement cardiovascular magnetic resonance is associated with subsequent hospitalization for heart failure.晚期钆增强心血管磁共振检测到的心肌损伤与随后因心力衰竭住院有关。
J Am Heart Assoc. 2013 Nov 18;2(6):e000416. doi: 10.1161/JAHA.113.000416.
3
Myocardial T1 mapping and extracellular volume quantification: a Society for Cardiovascular Magnetic Resonance (SCMR) and CMR Working Group of the European Society of Cardiology consensus statement.
T1 映射:一种评估系统性右心室的无创工具。
Int J Cardiovasc Imaging. 2024 Aug;40(8):1779-1785. doi: 10.1007/s10554-024-03168-x. Epub 2024 Jun 29.
4
The Role of T2 Mapping in Cardiac Amyloidosis.T2 映射在心脏淀粉样变性中的作用
Diagnostics (Basel). 2024 May 18;14(10):1048. doi: 10.3390/diagnostics14101048.
5
Native myocardial T1 and right ventricular size by CMR predict outcome in systemic sclerosis-associated pulmonary hypertension.心脏磁共振 native T1 值和右心室大小可预测系统性硬皮病相关肺动脉高压的预后。
Rheumatology (Oxford). 2024 Oct 1;63(10):2678-2683. doi: 10.1093/rheumatology/keae141.
6
Myocardial Fibrosis and Cardiomyopathy Risk: A Genetic Link in the MESA.心肌纤维化和心肌病风险:MESA 中的遗传联系。
Circ Heart Fail. 2023 Sep;16(9):e010262. doi: 10.1161/CIRCHEARTFAILURE.122.010262. Epub 2023 Aug 1.
7
Reference values of myocardial native T1 and T2 mapping values in normal Indian population at 1.5 Tesla scanner.1.5T 扫描仪下正常印度人群心肌 native T1 和 T2 映射值的参考值。
Int J Cardiovasc Imaging. 2022 Nov;38(11):2403-2411. doi: 10.1007/s10554-022-02648-2. Epub 2022 Jun 27.
8
The Dynamic Characteristics of Myocardial Contractility and Extracellular Volume in Type 2 Diabetes Mellitus Mice Investigated by 7.0T Cardiac Magnetic Resonance.7.0T心脏磁共振研究2型糖尿病小鼠心肌收缩力和细胞外容积的动态特征
J Clin Med. 2022 Jul 22;11(15):4262. doi: 10.3390/jcm11154262.
9
Myocardial Tissue Characterization in Heart Failure with Preserved Ejection Fraction: From Histopathology and Cardiac Magnetic Resonance Findings to Therapeutic Targets.心力衰竭伴射血分数保留的心肌组织特征化:从组织病理学和心脏磁共振成像结果到治疗靶点。
Int J Mol Sci. 2021 Jul 17;22(14):7650. doi: 10.3390/ijms22147650.
10
Examining the Relationship and Prognostic Implication of Diabetic Status and Extracellular Matrix Expansion by Cardiac Magnetic Resonance.检查糖尿病状态与心脏磁共振的细胞外基质扩张的关系及其预后意义。
Circ Cardiovasc Imaging. 2020 Jul;13(7):e011000. doi: 10.1161/CIRCIMAGING.120.011000. Epub 2020 Jul 15.
心肌 T1 映射和细胞外容积定量:心血管磁共振学会 (SCMR) 和欧洲心脏病学会 CMR 工作组的共识声明。
J Cardiovasc Magn Reson. 2013 Oct 14;15(1):92. doi: 10.1186/1532-429X-15-92.
4
T(1) mapping for the diagnosis of acute myocarditis using CMR: comparison to T2-weighted and late gadolinium enhanced imaging.CMR 用于诊断急性心肌炎的 T(1) 映射:与 T2 加权和晚期钆增强成像的比较。
JACC Cardiovasc Imaging. 2013 Oct;6(10):1048-1058. doi: 10.1016/j.jcmg.2013.03.008. Epub 2013 Sep 4.
5
T₁ mapping with cardiovascular MRI is highly sensitive for Fabry disease independent of hypertrophy and sex.心血管磁共振 T₁ 映射对于法布里病具有高度敏感性,与肥大和性别无关。
Circ Cardiovasc Imaging. 2013 Sep;6(5):637-45. doi: 10.1161/CIRCIMAGING.113.000482. Epub 2013 Aug 6.
6
Modified look-locker inversion recovery T1 mapping indices: assessment of accuracy and reproducibility between magnetic resonance scanners.改良的 Look-Locker 反转恢复 T1 映射指数:磁共振扫描仪间准确性和可重复性的评估。
J Cardiovasc Magn Reson. 2013 Jul 26;15(1):64. doi: 10.1186/1532-429X-15-64.
7
Saturation recovery single-shot acquisition (SASHA) for myocardial T(1) mapping.用于心肌T(1) 图谱分析的饱和恢复单次采集(SASHA)
Magn Reson Med. 2014 Jun;71(6):2082-95. doi: 10.1002/mrm.24878. Epub 2013 Jul 23.
8
Evaluation of age-related interstitial myocardial fibrosis with cardiac magnetic resonance contrast-enhanced T1 mapping: MESA (Multi-Ethnic Study of Atherosclerosis).心脏磁共振对比增强 T1 映射评估年龄相关性间质心肌纤维化:MESA(动脉粥样硬化的多民族研究)。
J Am Coll Cardiol. 2013 Oct 1;62(14):1280-1287. doi: 10.1016/j.jacc.2013.05.078. Epub 2013 Jul 17.
9
Myocardial extracellular volume fraction quantified by cardiovascular magnetic resonance is increased in diabetes and associated with mortality and incident heart failure admission.心血管磁共振定量的心肌细胞外容积分数在糖尿病中增加,并与死亡率和心力衰竭入院事件相关。
Eur Heart J. 2014 Mar;35(10):657-64. doi: 10.1093/eurheartj/eht193. Epub 2013 Jun 11.
10
T1 mapping for myocardial extracellular volume measurement by CMR: bolus only versus primed infusion technique.CMR 测量心肌细胞外容积的 T1 映射:仅团注对比首剂团注技术。
JACC Cardiovasc Imaging. 2013 Sep;6(9):955-62. doi: 10.1016/j.jcmg.2013.01.011. Epub 2013 Apr 10.